These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17235473)

  • 41. [Motivation of patients to participate in clinical trials. An explorative survey].
    Gaul C; Malcherczyk A; Schmidt T; Helm J; Haerting J
    Med Klin (Munich); 2010 Feb; 105(2):73-9. PubMed ID: 20174906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drivers and barriers to patient participation in RCTs.
    Jenkins V; Farewell V; Farewell D; Darmanin J; Wagstaff J; Langridge C; Fallowfield L;
    Br J Cancer; 2013 Apr; 108(7):1402-7. PubMed ID: 23511558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adolescent experiences in a vaccine trial: a pilot study.
    Abrams A; Siegfried N; Geldenhuys H
    S Afr Med J; 2011 Nov; 101(12):884-6. PubMed ID: 22273030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Motivation of patients with inflammatory bowel disease to participate in a clinical trial.
    Gehrmann U; Berger U; Teich N; Bruns T; Stallmach A; Weber M
    Z Gastroenterol; 2016 Oct; 54(10):1123-1129. PubMed ID: 27723903
    [No Abstract]   [Full Text] [Related]  

  • 45. Barriers to and facilitators of participation of older adults in a placebo-controlled randomized clinical trial.
    van de Glind EM; Vural EM; Scholten E; Hooft L; Portegijs E; van Munster BC; de Rooij SE
    J Am Geriatr Soc; 2013 Aug; 61(8):1421-2. PubMed ID: 23937496
    [No Abstract]   [Full Text] [Related]  

  • 46. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.
    Unger JM; Vaidya R; Hershman DL; Minasian LM; Fleury ME
    J Natl Cancer Inst; 2019 Mar; 111(3):245-255. PubMed ID: 30856272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences in trial knowledge and motives for participation among cancer patients in phase 3 clinical trials.
    Godskesen TM; Kihlbom U; Nordin K; Silén M; Nygren P
    Eur J Cancer Care (Engl); 2016 May; 25(3):516-23. PubMed ID: 25904313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trends in Consent for Clinical Trials in Cardiovascular Disease.
    Kerkhoff LA; Butler J; Kelkar AA; Shore S; Speight CD; Wall LK; Dickert NW
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27317350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cultural aspects of the patient-doctor relationship.
    Aziz VM
    Int Psychogeriatr; 2009 Apr; 21(2):415-7. PubMed ID: 19040785
    [No Abstract]   [Full Text] [Related]  

  • 50. Overcoming Barriers to Clinical Trial Enrollment.
    Nipp RD; Hong K; Paskett ED
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():105-114. PubMed ID: 31099636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Informing participants of allocation to placebo at trial closure: postal survey.
    Di Blasi Z; Kaptchuk TJ; Weinman J; Kleijnen J
    BMJ; 2002 Dec; 325(7376):1329. PubMed ID: 12468480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantifying the recruitment challenges with couple-based interventions for cancer: applications to early-stage breast cancer.
    Fredman SJ; Baucom DH; Gremore TM; Castellani AM; Kallman TA; Porter LS; Kirby JS; Dees EC; Klauber-Demore N; Peppercorn J; Carey LA
    Psychooncology; 2009 Jun; 18(6):667-73. PubMed ID: 19061201
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modeling factors influencing enrollment in family-focused preventive intervention research.
    Spoth R; Redmond C; Shin C
    Prev Sci; 2000 Dec; 1(4):213-25. PubMed ID: 11523749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Viewpoints and concerns of a clinical trial participant.
    Joseph RR
    Cancer; 1994 Nov; 74(9 Suppl):2692-3. PubMed ID: 7954288
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical trials in cancer therapy: efforts to improve patient enrollment by community oncologists.
    Fisher WB; Cohen SJ; Hammond MK; Turner S; Loehrer PJ
    Med Pediatr Oncol; 1991; 19(3):165-8. PubMed ID: 2023564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Understanding cognitive processes behind acceptance or refusal of phase I trials.
    Pravettoni G; Mazzocco K; Gorini A; Curigliano G
    Crit Rev Oncol Hematol; 2016 Apr; 100():69-73. PubMed ID: 26852078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Barriers to clinical trials. Part II: Knowledge and attitudes of potential participants.
    Schain WS
    Cancer; 1994 Nov; 74(9 Suppl):2666-71. PubMed ID: 7954283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Qualitative differences among cancer clinical trial explanations.
    Roberts F
    Soc Sci Med; 2002 Dec; 55(11):1947-55. PubMed ID: 12406463
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Animations about Clinical Trial Participation for Cancer Patients and Survivors.
    Occa A; Morgan SE
    J Health Commun; 2019; 24(10):749-760. PubMed ID: 31543072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Community-based recruitment and enrollment for a clinical trial on the sensitive issue of fecal incontinence: the Fiber study.
    Whitebird RR; Bliss DZ; Hase KA; Savik K
    Res Nurs Health; 2006 Jun; 29(3):233-43. PubMed ID: 16676338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.